A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group.

已完结 10 由 yuyuyu 发布于 2024/11/2 10:05:10

DOI:10.1097/00007890-199903150-00015
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1097/00007890-199903150-00015

其它数据库

Abstract：Background: T-cell activation through T-cell receptor engagement requires co-stimulatory molecules and also adhesion molecules such as ICAM-1. Moreover ICAM-1 mediates leukocyte invasion fro

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Physical Society (APS)Machine learning based nonlocal kinetic energy density functional for simple metals and alloys